Development

Cynthia A. Challener, PhD, is a contributing editor to BioPharm International.

Articles

Preparing for variability and flexible processing are necessary for success.

Managing Raw Material Variability for Autologous Cell Therapies

Feliza Mirasol is the science editor for 

Dujuan Lu, PhD, global leader—E&L, SGS Health Sciences, recommends some key issues that pharma manufacturers should consider when formulating products that require a medical device.

Key E&L Issues to Consider During Formulation (AAPS PharmSci 360)

There is no such thing as a perfect linker.

Optimization of Linker Chemistries for Antibody-Drug Conjugates

Sara Fathollahi, PhD, product application specialist at DFE Pharma, makes the case of how excipient suppliers can support the transition from batch to continuous manufacturing.

A Look at How Excipient Suppliers Can Support Adoption of Continuous Manufacturing (AAPS PharmSci 360)

Editor of Pharmaceutical Technology Europe

Biologics formulation comes with a unique set of challenges, which can be overcome through innovative strategies and good partnerships. 

Navigating Biologics Development

Andreas Dreps, PhD, is SVP, Drug Development Services at ICON

Martin Lachs, PhD, is VP, Project Management Oncology at ICON.

Despite its success, clinical and logistical roadblocks to mRNA cancer vaccine development remain.

Logistical Considerations in mRNA Vaccine Development

Nanoparticles offer the potential for a safer, more effective method of drug delivery to the patient.

Nanoparticle Engineering in Drug Delivery Under the Microscope

When one is using continuous hot-melt extrusion to enhance solubility, process control is essential.

Addressing Poorly Soluble APIs with Continuous Hot-Melt Extrusion

Podcasts

Hanns-Christian Mahler and Andrea Allmendinger from ten23 health will discuss some key aspects of biologic drug development and manufacturing.

Drug Solutions Podcast: Considering Biologic Drug Development and Manufacturing Holistically

This deal would help the companies merge to work on future projects and conduct research together.